A Phase III Trial to Assess the Safety and Immunogenicity of a HIPRA's Candidate Booster Vaccination Against COVID-19.
Clinical trial NCT05246137 · COMPLETED
Trial details
- NCT number
- NCT05246137
- Sponsor
- Hipra Scientific, S.L.U
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-03
- Primary completion
- 2022-03-03
- Enrollment
- 2646
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.